Detailed report on Asia-Pacific In Vitro Diagnostics Market 2022

1
Asia-Pacific In Vitro Diagnostics - Market
Opportunities and Forecasts, 2015 - 2022
Published Date 01 March, 2016 No of Pages
130 Single User Price 2850
Asia-Pacific In Vitro Diagnostics Market
registering a CAGR of 5.6 over the forecast
period
Click Here To Check Complete Report
2

• In vitro diagnostics (IVD) is a method used for
  detection and identification of diseases in an
  artificial environment using samples such as
  blood, urine, stool, tissues and other body
  fluids, which are derived from the human body.
• IVD includes several techniques such as
  immunodiagnostic, infectious diseases testing,
  blood testing, clinical chemistry, molecular
  diagnosis and other such techniques.
• Considerable increase in the number of chronic
  and infectious diseases, growing awareness
  towards healthcare solutions and technological
  advancements in healthcare industry encouraged
  doctors and researchers to shift their focus from
  traditional diagnostic methods to personalized
  medicines.
• The overall revenue of the Asia Pacific IVD
  market accounted for about 12.9 billion in 2015,
  and is estimated to reach 19.0 billion by 2022,
  registering a CAGR of 5.6 over the forecast
  period.
• The increased application of personalized
  medicines and widespread knowledge of rare
  diseases are boosting the growth of Asia Pacific
  IVD market.
• Moreover, growing need of IVD testing owing to
  increasing incidences of chronic and infectious
  diseases and growing geriatric population prone
  to immunological disorders drives the market
  growth.

3

• The Asia Pacific IVD market has evolved over the
  years with the launch of several innovative
  techniques used across multiple therapeutic
  areas.
• However, stringent regulatory policies and
  reimbursements issues in few countries limit the
  growth of this market.
• The rising demand for technologically advanced
  diagnostic devices, rise in GDP and per capita
  income and rise in disposable incomes facilitate
  a huge potential for the Asia Pacific IVD market
  in the Asia-Pacific region.
• Similarly, the development of a new range of
  condition-specific markers and tests along with
  the advancement in genomics and proteomics are
  creating new opportunities in emerging economies.
  
• The Asia-Pacific IVD market is segmented based on
  product type, technique, indications, end user
  and country.
• Based on technique, the market is segmented into
  immunodiagnostics, blood testing, molecular
  diagnostics, tissue diagnostics, clinical
  chemistry and other clinical technique.
  Immunodiagnostic is the highest
  revenue-generating segment in the overall IVD
  techniques market.

4

• However, the blood testing is the fastest growing
  technique in the overall IVD techniques market
  due to its ability to accurately detect the
  primary cause of the disease.
• Based on product type, the market is segmented
  into instruments, reagents, services software.
• Reagents held the highest market share in the
  Asia Pacific IVD market followed by rapidly
  growing instrument segment.
• Reagents are largely used in various equipment
  and play a key role in the overall diagnosis
  process.
• The application segment is categorized into
  infectious diseases, cancer, cardiac diseases,
  immune system diseases, nephrological diseases,
  gastrointestinal diseases, and others.
• Infectious diseases segment was the highest
  revenue-generating segment in 2015 and would
  continue to maintain its position throughout the
  forecast period, due to the rise in incidences of
  infectious diseases such as HIV/AIDS, Chlamydia
  and Hepatitis.

5

• Hospitals and laboratories, academics medical
  schools, point-of-care testing and others form
  the end users segment in the Asia-Pacific IVD
  market.
• Stand-alone laboratories generate the highest
  revenue, followed by hospitals.
• A significant rise in the number of hospitals and
  laboratories across the Asia-Pacific region along
  with increased awareness about developments in
  healthcare largely contribute to the growth of
  these segment.
• Based on country, the Asia-Pacific IVD market is
  segmented into India, China, Japan, Australia,
  and other Asia-Pacific countries.
• Japan held the dominant share, around 35.3 in
  2015 in the Asia-Pacific IVD market, owing to the
  high demand for testing in outpatient clinics,
  huge population base and rising medical insurance
  services by the Japan government.
• Moreover, China and Australia hold the
  significant market share due to the
  well-supported reimbursement facilities and
  well-regulated IVD devices, which comes under the
  regulation of medical devices.

Make an Inquiry Before Buying
6

• However, India registers highest CAGR i.e. 7.1
  during the forecast period. Product launch was
  the key strategy adopted by market payers, owing
  to the dynamic nature of the market in terms of
  technology advancement.
• The leading companies profiled in this report
  are, Danaher Corporation, Vela Diagnostics,
  Siemens AG, Affymetrix, Alere Inc., BioMerieux,
  Roche Diagnostics, Bio-Rad Laboratories, Becton,
  Dickinson And Company, Abbott Laboratories Inc.,
  Arkray Inc., Sysmex Corporation, Johnson
  Johnson, Siemens Healthcare and Trans Asia
  BioMedicals Ltd.
• KEY BENEFITS FOR STAKEHOLDERS This report
  entails the detailed quantitative analysis of the
  current market and estimations from 2015 to 2022,
  which assists in identifying the prevailing
  market opportunities Exhaustive analysis of the
  Asia Pacific IVD market by product type helps in
  understanding the types of instruments and
  reagents that are currently being used during
  disease diagnostic that would gain prominence in
  the future Country-wise Asia Pacific IVD market
  conditions are comprehensively analyzed in this
  report.

Download Sample Brochure
7

• Increasing awareness about chronic diseases in
  developing economies is expected to drive the
  growth of the market Extensive analysis of the
  market is conducted by following key product
  positioning and monitoring the top competitors
  within the market framework Key market players
  within the Asia Pacific IVD market are profiled
  in this report and their strategies are analyzed
  thoroughly, which helps in understanding
  competitive outlook of Asia Pacific IVD
  marketplace IVD MARKET KEY SEGMENTS
• By Product type ReagentsInstrumentsSoftware
  Services
• By Techniques ImmunodiagnosticsBlood
  TestingMolecular DiagnosticsTissue
  DiagnosticsClinical ChemistryOther IVD Techniques
• By Application Infectious DiseasesCancerCardiac
  DiseasesImmune System DisordersNephrological
  DiseasesGastrointestinal DiseasesOther
  Indications
• By End Users Standalone LaboratoryHospitalsAcademi
  c Medical SchoolsPoint of CareOthers
• By Country IndiaChinaJapanAustraliaOthers

8
Asia-Pacific In Vitro Diagnostics - Market
Opportunities and Forecasts, 2015 - 2022
A detailed qualitative analysis of the factors
responsible for driving and restraining growth of
the Asia-Pacific In Vitro Diagnostics Market and
future opportunities are provided in the report.
Contact 1-302-261-5343 sales_at_marketintelreports.
com www.marketintelreports.com
Click here to order a copy of Asia-Pacific In
Vitro Diagnostics Market Report